Shares of Laurus Labs Ltd. opened lower on Friday, October 24, even after the company's September quarter results came in above analyst expectations on...
Drug firm Laurus Labs Ltd on Thursday (October 23) has provided its outlook for FY 2026, projecting continued strength in business momentum seen during...
Laurus Labs Ltd. reported its results for the September quarter on Thursday, October 23, which were higher than analyst expectations on most parameters.Revenue for...